Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 29.10.2024
Pharming Group NV
Company Name:
Pharming Group NV
ISIN:
NL0010391025
Reason for the research:
Q3/24 results
Recommendation:
Buy
from:
29.10.2024
Target price:
€1.70
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010 [ … ]
Tue, 29.10.2024
Knaus Tabbert AG
Company Name:
Knaus Tabbert AG
ISIN:
DE000A2YN504
Reason for the research:
Update
Recommendation:
Kaufen
from:
29.10.2024
Target price:
€54
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) verö [ … ]
Tue, 29.10.2024
q.beyond AG
Company Name:
q.beyond AG
ISIN:
DE0005137004
Reason for the research:
Update
Recommendation:
Buy
from:
29.10.2024
Target price:
EUR 1.10
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Q3 preview: Stable development & improved consulting; chg.
q.beyond will release its Q3 report on Novem [ … ]
Tue, 29.10.2024
CR Energy AG
Company Name:
CR Energy AG
ISIN:
DE000A2GS625
Reason for the research:
Update
Recommendation:
Buy
from:
29.10.2024
Target price:
EUR 12.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Positive operating development in H1
Topic: CR Energy released its H1 report, which shows a strong operat [ … ]
Mon, 28.10.2024
Cardiol Therapeutics Inc
Company Name:
Cardiol Therapeutics Inc
ISIN:
CA14161Y2006
Reason for the research:
Update
Recommendation:
Buy
from:
28.10.2024
Target price:
USD8.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISI [ … ]
Fri, 25.10.2024
ZEAL Network SE
Company Name:
ZEAL Network SE
ISIN:
DE000ZEAL241
Reason for the research:
Update
Recommendation:
Buy
from:
25.10.2024
Target price:
EUR 57.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Guidance hike confirms strong momentum; chg. est & PT
Yesterday after the bell, ZEAL released an ad-h [ … ]
Fri, 25.10.2024
USU Software AG
Company Name:
USU Software AG
ISIN:
DE000A0BVU28
Reason for the research:
Update
Recommendation:
Buy
from:
25.10.2024
Target price:
EUR 30.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Revisiting USU: An appealing special situation
Half a year ago we put out our last piece on USU, advis [ … ]
Thu, 24.10.2024
Aspermont Ltd.
Company Name:
Aspermont Ltd.
ISIN:
AU000000ASP3
Reason for the research:
Research Report (Note)
Recommendation:
Buy
Target price:
0.02 EUR
Target price on sight of:
30.09.2025
Last rating change:
Analyst:
Julien Desrosiers, Matthias Greiffenberger
You can download the research here: http://www.more-ir.de/d/31107.pdf
Contact [ … ]
Wed, 23.10.2024
Telefonica Deutschland Holding AG
Company Name:
Telefonica Deutschland Holding AG
ISIN:
DE000A1J5RX9
Reason for the research:
Special Situation
Recommendation:
Buy
from:
23.10.2024
Target price:
€3.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Kevin Sheil
First Berlin Equity Research on 23.10.2024 initiated coverage on Telefonica D [ … ]
Wed, 23.10.2024
R. STAHL AG
Company Name:
R. STAHL AG
ISIN:
DE000A1PHBB5
Reason for the research:
Update
Recommendation:
Buy
from:
23.10.2024
Target price:
EUR 29.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Christian Sandherr
Solid Q3 preview // FY guidance in reach
Topic: R. Stahl will release its Q3 report on November 6th. We e [ … ]